Genmab A (GMAB) Cash & Current Investments (2023 - 2026)
Genmab A (GMAB) posted Cash & Current Investments of $1.5 billion for the quarter ended Jun 30, 2026, down 1.2% from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Cash & Current Investments (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Genmab A's Cash & Current Investments came in at $1.72 billion, up 106.9% from the prior year.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of -1.7% (years ended Dec 2020 to Dec 2025).
- In prior years, Genmab A's Cash & Current Investments was $829.1 million in the year ended Dec 31, 2024 (-33.0%), $1.24 billion in the year ended Dec 31, 2023 (-40.6%), $2.08 billion in the year ended Dec 31, 2022 (-4.7%) and $2.19 billion in the year ended Dec 31, 2021 (+17.0%).
- Quarterly Cash & Current Investments has run from a low of $635.93 million in the quarter ended Sep 30, 2025 to a high of $3.2 billion in the quarter ended Jan 1, 2023 over five years.
- On a year-over-year basis, Cash & Current Investments increased in 1 of the last four quarters, with an average decline of 0.8%.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was the quarter ended Jun 30, 2025, with growth of 96.8%; the weakest was the quarter ended Sep 30, 2021, with a decline of 87.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Genmab A | 2.81 Bn | -2.56 Bn | 1.07 Bn | 1.50 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.50 Bn |
| Mar 31, 2026 | 1.52 Bn |
| Dec 31, 2025 | 1.72 Bn |
| Sep 30, 2025 | 635.93 Mn |
| Jun 30, 2025 | 2.90 Bn |
| Mar 31, 2025 | 1.70 Bn |
| Dec 31, 2024 | 2.95 Bn |
| Sep 30, 2024 | 43.00 Mn |
| Jun 30, 2024 | 624.00 Mn |
| Mar 31, 2024 | 130.00 Mn |
| Dec 31, 2023 | 4.17 Bn |
| Mar 31, 2023 | 705.00 Mn |
| Jan 1, 2023 | 3.20 Bn |
API Access
Genmab A Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();